ArticleCureus2025
Knowledge, Attitudes and Practices of Japanese Cardiovascular Surgeons on the Management of Surgical Site Complications and Prophylactic Single-Use Negative Pressure Wound Therapy After Coronary Artery Bypass Surgery: A Quantitative Survey.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective This study assessed the knowledge, attitudes and practices of cardiovascular surgeons in Japan on prophylactic single-use negative pressure wound therapy (sNPWT) after coronary artery bypass grafting (CABG). Methods A survey was distributed online to an anonymous Japanese market research panel in April 2024 (target: 50 responses). Eligible respondents were cardiovascular surgeons practising in Japan, with five or more years of experience and having performed 20 or more CABG surgeries in the past year. Responses were analysed descriptively. Results Among the 50 respondents (38% general, 30% national/public, 24% university hospitals), most agreed that the consequences of surgical site complications (SSCs) following cardiovascular surgery were more severe than other surgeries (78%), that SSC prevention is a priority after CABG (80%), and that postoperative procedures are important for managing SSC risk (84%). However, sNPWT was rarely used routinely (2%). Only 24% reported prophylactic sNPWT use; 44% used sNPWT only upon signs of SSCs. Cost-related factors were important to 60‒70% of respondents in determining SSC prevention. There was low knowledge of approved indications and reimbursement criteria for sNPWT. While 52% would recommend prophylactic sNPWT, limited reimbursement (80%) and insufficient familiarity with safety (52%) and effectiveness (50%) data were reasons for non-use. Sixty percent of respondents agreed that Japan-specific sNPWT guidelines are needed. Conclusions Barriers to using prophylactic sNPWT in Japan include complex and limited reimbursement criteria, cost concerns, insufficient local evidence and low awareness of existing evidence. Addressing these challenges may encourage prophylactic sNPWT use, leading to reduced postoperative complications, lower healthcare costs, and minimised disparities in care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.